E&G Advisors’s GSK GSK Stock Holding History

E&G Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,200	Closed	-$231K	–	201
2017 Q4	$231K	Buy	+5,200	New	+$240K	0.1%	187

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

E&G Advisors's GSK Position: Q1 2018 in Review

E&G Advisors sold out of GSK (GSK) in Q1 2018, closing a stake of 5,200 shares — an estimated $231K sold.

E&G Advisors first reported a position in GSK in Q4 2017 and held it in 1 quarter. The position peaked at $231K in Q4 2017. 778 funds tracked by Wall St. Rank hold GSK as of Q1 2018.

E&G Advisors reported no remaining GSK position as of Q1 2018 after selling out during the quarter.
E&G Advisors sold 5,200 GSK shares in Q1 2018, an estimated $231K.
E&G Advisors first reported a position in GSK in Q4 2017 and held it in 1 quarter.
E&G Advisors's GSK position peaked at $231K in Q4 2017.
778 funds tracked by Wall St. Rank held GSK as of Q1 2018.

Based on E&G Advisors's 13F filing for Q1 2018, filed 18 Apr 2018.